Crossmark

Clinical diagnostic value of CRISPR-Cas13a-based molecular technology for tuberculosis

Crossref DOI link: https://doi.org/10.1007/s11845-024-03799-y

Published Online: 2024-09-19

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wu, Kai

Wu, Zhenyao

Li, Xiongjie https://orcid.org/0009-0009-2377-124X
License Information

Text and Data Mining valid from 2024-09-19

Version of Record valid from 2024-09-19
More Information

Article History

Received: 7 April 2024

Accepted: 29 August 2024

First Online: 19 September 2024

Declarations

:

: The authors declare no competing interests.